(Q43172275)

15 November 2017

title

Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC? (English)

1 reference

primary sclerosing cholangitis

15 November 2017

main subject

ascending cholangitis

0 references

sclerosing cholangitis

1 reference

based on heuristic

inferred from title

1 reference

Roger W Chapman

1

1 reference

15 November 2017

language of work or name

English

0 references

publication date

1 February 2010

1 reference

Nature Reviews Gastroenterology & Hepatology

15 November 2017

published in

1 reference

15 November 2017

volume

7

1 reference

15 November 2017

issue

2

1 reference

15 November 2017

page(s)

74-75

1 reference

An update on primary sclerosing cholangitis.

15 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.235

High-dose ursodeoxycholic acid in the treatment of primary sclerosing cholangitis: throwing the urso out with the bathwater?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.235

Ursodiol for primary sclerosing cholangitis. Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.235

High-dose ursodeoxycholic acid in primary sclerosing cholangitis: a 5-year multicenter, randomized, controlled study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.235

High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.235

High-dose ursodeoxycholic acid as a therapy for patients with primary sclerosing cholangitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.235

High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.235

Ursodeoxycholic acid aggravates bile infarcts in bile duct-ligated and Mdr2 knockout mice via disruption of cholangioles

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.235

A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.235

Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRGASTRO.2009.235

10.1038/NRGASTRO.2009.235

31 March 2020

Identifiers

DOI

1 reference

15 November 2017

1 reference